These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 23157337

  • 1. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load.
    Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust WJ, Soreq H.
    Curr Alzheimer Res; 2013 Jan; 10(1):48-56. PubMed ID: 23157337
    [Abstract] [Full Text] [Related]

  • 2. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014 Jan; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
    Grimmer T, Riemenschneider M, Förstl H, Henriksen G, Klunk WE, Mathis CA, Shiga T, Wester HJ, Kurz A, Drzezga A.
    Biol Psychiatry; 2009 Jun 01; 65(11):927-34. PubMed ID: 19268916
    [Abstract] [Full Text] [Related]

  • 5. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
    Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.
    Neurology; 2006 Nov 14; 67(9):1575-80. PubMed ID: 16971697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD, Buckley CJ, Abrahamson EE, Kofler JK, Mathis CA, Klunk WE, Farrar G.
    Acta Neuropathol; 2020 Oct 14; 140(4):463-476. PubMed ID: 32772265
    [Abstract] [Full Text] [Related]

  • 8. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5949-54. PubMed ID: 20231448
    [Abstract] [Full Text] [Related]

  • 9. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
    Driscoll I, Troncoso JC, Rudow G, Sojkova J, Pletnikova O, Zhou Y, Kraut MA, Ferrucci L, Mathis CA, Klunk WE, O'Brien RJ, Davatzikos C, Wong DF, Resnick SM.
    Acta Neuropathol; 2012 Dec 30; 124(6):823-31. PubMed ID: 22864813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 12. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 15; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 13. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T, Kakimoto A, Yoshikawa E, Terada T, Ouchi Y.
    J Alzheimers Dis; 2019 Nov 15; 69(2):529-538. PubMed ID: 31104023
    [Abstract] [Full Text] [Related]

  • 14. Antibody engagement with amyloid-beta does not inhibit [11C]PiB binding for PET imaging.
    Xiong M, Dahlén A, Roshanbin S, Wik E, Aguilar X, Eriksson J, Sehlin D, Syvänen S.
    J Neurochem; 2024 Sep 15; 168(9):2601-2610. PubMed ID: 38721627
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
    Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.
    Neurology; 2007 May 08; 68(19):1603-6. PubMed ID: 17485647
    [Abstract] [Full Text] [Related]

  • 17. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
    Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, Xiong C, Bateman RJ, Ghetti B, Ringman JM, Chhatwal J, Masters CL, McLean C, Lashley T, Su Y, Koeppe R, Jack C, Klunk WE, Morris JC, Perrin RJ, Cairns NJ, Benzinger TLS.
    Acta Neuropathol; 2021 Oct 08; 142(4):689-706. PubMed ID: 34319442
    [Abstract] [Full Text] [Related]

  • 18. Differences in Aβ brain networks in Alzheimer's disease and healthy controls.
    Duan H, Jiang J, Xu J, Zhou H, Huang Z, Yu Z, Yan Z, Alzheimer's Disease Neuroimaging Initiative.
    Brain Res; 2017 Jan 15; 1655():77-89. PubMed ID: 27867033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.
    Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Någren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO.
    Brain; 2008 Jul 15; 131(Pt 7):1845-53. PubMed ID: 18583368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.